Gwen Schroyen
Gwen Schroyen
1Leuven Brain Institute, KU Leuven, 3000 Leuven, Belgium; jeroen.blommaert@kuleuven.be (J.B.); charlotte.sleurs@kuleuven.be (C.S.); mathieu.vandenbulcke@kuleuven.be (M.V.); nina.dedoncker@kuleuven.be (N.D.); an.goris@kuleuven.be (A.G.); koen.vanlaere@kuleuven.be (K.v.L.); stefan.sunaert@kuleuven.be (S.S.); sabine.deprez@kuleuven.be (S.D.)
2Leuven Cancer Institute, KU Leuven, 3000 Leuven, Belgiummichel.koole@kuleuven.be (M.K.); ann.smeets@kuleuven.be (A.S.)
3Department of Imaging and Pathology, KU Leuven, 3000 Leuven, Belgium
1,2,3,*,
Jeroen Blommaert
Jeroen Blommaert
1Leuven Brain Institute, KU Leuven, 3000 Leuven, Belgium; jeroen.blommaert@kuleuven.be (J.B.); charlotte.sleurs@kuleuven.be (C.S.); mathieu.vandenbulcke@kuleuven.be (M.V.); nina.dedoncker@kuleuven.be (N.D.); an.goris@kuleuven.be (A.G.); koen.vanlaere@kuleuven.be (K.v.L.); stefan.sunaert@kuleuven.be (S.S.); sabine.deprez@kuleuven.be (S.D.)
2Leuven Cancer Institute, KU Leuven, 3000 Leuven, Belgiummichel.koole@kuleuven.be (M.K.); ann.smeets@kuleuven.be (A.S.)
4Department of Oncology, KU Leuven, 3000 Leuven, Belgium
1,2,4,
Donatienne van Weehaeghe
Donatienne van Weehaeghe
5Department of Nuclear Medicine and Molecular Imaging, KU Leuven, 3000 Leuven, Belgium; donatienne.vanweehaeghe@kuleuven.be
6Nuclear Medicine and Molecular Imaging, University Hospitals Leuven, 3000 Leuven, Belgium
5,6,
Charlotte Sleurs
Charlotte Sleurs
1Leuven Brain Institute, KU Leuven, 3000 Leuven, Belgium; jeroen.blommaert@kuleuven.be (J.B.); charlotte.sleurs@kuleuven.be (C.S.); mathieu.vandenbulcke@kuleuven.be (M.V.); nina.dedoncker@kuleuven.be (N.D.); an.goris@kuleuven.be (A.G.); koen.vanlaere@kuleuven.be (K.v.L.); stefan.sunaert@kuleuven.be (S.S.); sabine.deprez@kuleuven.be (S.D.)
2Leuven Cancer Institute, KU Leuven, 3000 Leuven, Belgiummichel.koole@kuleuven.be (M.K.); ann.smeets@kuleuven.be (A.S.)
4Department of Oncology, KU Leuven, 3000 Leuven, Belgium
1,2,4,
Mathieu Vandenbulcke
Mathieu Vandenbulcke
1Leuven Brain Institute, KU Leuven, 3000 Leuven, Belgium; jeroen.blommaert@kuleuven.be (J.B.); charlotte.sleurs@kuleuven.be (C.S.); mathieu.vandenbulcke@kuleuven.be (M.V.); nina.dedoncker@kuleuven.be (N.D.); an.goris@kuleuven.be (A.G.); koen.vanlaere@kuleuven.be (K.v.L.); stefan.sunaert@kuleuven.be (S.S.); sabine.deprez@kuleuven.be (S.D.)
7Department of Neurosciences, KU Leuven, 3000 Leuven, Belgium
8Psychiatry, University Hospitals Leuven, 3000 Leuven, Belgium
1,7,8,
Nina Dedoncker
Nina Dedoncker
1Leuven Brain Institute, KU Leuven, 3000 Leuven, Belgium; jeroen.blommaert@kuleuven.be (J.B.); charlotte.sleurs@kuleuven.be (C.S.); mathieu.vandenbulcke@kuleuven.be (M.V.); nina.dedoncker@kuleuven.be (N.D.); an.goris@kuleuven.be (A.G.); koen.vanlaere@kuleuven.be (K.v.L.); stefan.sunaert@kuleuven.be (S.S.); sabine.deprez@kuleuven.be (S.D.)
7Department of Neurosciences, KU Leuven, 3000 Leuven, Belgium
1,7,
Sigrid Hatse
Sigrid Hatse
2Leuven Cancer Institute, KU Leuven, 3000 Leuven, Belgiummichel.koole@kuleuven.be (M.K.); ann.smeets@kuleuven.be (A.S.)
4Department of Oncology, KU Leuven, 3000 Leuven, Belgium
2,4,
An Goris
An Goris
1Leuven Brain Institute, KU Leuven, 3000 Leuven, Belgium; jeroen.blommaert@kuleuven.be (J.B.); charlotte.sleurs@kuleuven.be (C.S.); mathieu.vandenbulcke@kuleuven.be (M.V.); nina.dedoncker@kuleuven.be (N.D.); an.goris@kuleuven.be (A.G.); koen.vanlaere@kuleuven.be (K.v.L.); stefan.sunaert@kuleuven.be (S.S.); sabine.deprez@kuleuven.be (S.D.)
7Department of Neurosciences, KU Leuven, 3000 Leuven, Belgium
1,7,
Michel Koole
Michel Koole
2Leuven Cancer Institute, KU Leuven, 3000 Leuven, Belgiummichel.koole@kuleuven.be (M.K.); ann.smeets@kuleuven.be (A.S.)
5Department of Nuclear Medicine and Molecular Imaging, KU Leuven, 3000 Leuven, Belgium; donatienne.vanweehaeghe@kuleuven.be
2,5,
Ann Smeets
Ann Smeets
2Leuven Cancer Institute, KU Leuven, 3000 Leuven, Belgiummichel.koole@kuleuven.be (M.K.); ann.smeets@kuleuven.be (A.S.)
4Department of Oncology, KU Leuven, 3000 Leuven, Belgium
9Surgical Oncology, University Hospitals Leuven, 3000 Leuven, Belgium
2,4,9,
Koen van Laere
Koen van Laere
1Leuven Brain Institute, KU Leuven, 3000 Leuven, Belgium; jeroen.blommaert@kuleuven.be (J.B.); charlotte.sleurs@kuleuven.be (C.S.); mathieu.vandenbulcke@kuleuven.be (M.V.); nina.dedoncker@kuleuven.be (N.D.); an.goris@kuleuven.be (A.G.); koen.vanlaere@kuleuven.be (K.v.L.); stefan.sunaert@kuleuven.be (S.S.); sabine.deprez@kuleuven.be (S.D.)
3Department of Imaging and Pathology, KU Leuven, 3000 Leuven, Belgium
5Department of Nuclear Medicine and Molecular Imaging, KU Leuven, 3000 Leuven, Belgium; donatienne.vanweehaeghe@kuleuven.be
6Nuclear Medicine and Molecular Imaging, University Hospitals Leuven, 3000 Leuven, Belgium
1,3,5,6,
Stefan Sunaert
Stefan Sunaert
1Leuven Brain Institute, KU Leuven, 3000 Leuven, Belgium; jeroen.blommaert@kuleuven.be (J.B.); charlotte.sleurs@kuleuven.be (C.S.); mathieu.vandenbulcke@kuleuven.be (M.V.); nina.dedoncker@kuleuven.be (N.D.); an.goris@kuleuven.be (A.G.); koen.vanlaere@kuleuven.be (K.v.L.); stefan.sunaert@kuleuven.be (S.S.); sabine.deprez@kuleuven.be (S.D.)
3Department of Imaging and Pathology, KU Leuven, 3000 Leuven, Belgium
10Radiology, University Hospitals Leuven, 3000 Leuven, Belgium
1,3,10,†,
Sabine Deprez
Sabine Deprez
1Leuven Brain Institute, KU Leuven, 3000 Leuven, Belgium; jeroen.blommaert@kuleuven.be (J.B.); charlotte.sleurs@kuleuven.be (C.S.); mathieu.vandenbulcke@kuleuven.be (M.V.); nina.dedoncker@kuleuven.be (N.D.); an.goris@kuleuven.be (A.G.); koen.vanlaere@kuleuven.be (K.v.L.); stefan.sunaert@kuleuven.be (S.S.); sabine.deprez@kuleuven.be (S.D.)
2Leuven Cancer Institute, KU Leuven, 3000 Leuven, Belgiummichel.koole@kuleuven.be (M.K.); ann.smeets@kuleuven.be (A.S.)
3Department of Imaging and Pathology, KU Leuven, 3000 Leuven, Belgium
1,2,3,†
1Leuven Brain Institute, KU Leuven, 3000 Leuven, Belgium; jeroen.blommaert@kuleuven.be (J.B.); charlotte.sleurs@kuleuven.be (C.S.); mathieu.vandenbulcke@kuleuven.be (M.V.); nina.dedoncker@kuleuven.be (N.D.); an.goris@kuleuven.be (A.G.); koen.vanlaere@kuleuven.be (K.v.L.); stefan.sunaert@kuleuven.be (S.S.); sabine.deprez@kuleuven.be (S.D.)
2Leuven Cancer Institute, KU Leuven, 3000 Leuven, Belgiummichel.koole@kuleuven.be (M.K.); ann.smeets@kuleuven.be (A.S.)
3Department of Imaging and Pathology, KU Leuven, 3000 Leuven, Belgium
4Department of Oncology, KU Leuven, 3000 Leuven, Belgium
5Department of Nuclear Medicine and Molecular Imaging, KU Leuven, 3000 Leuven, Belgium; donatienne.vanweehaeghe@kuleuven.be
6Nuclear Medicine and Molecular Imaging, University Hospitals Leuven, 3000 Leuven, Belgium
7Department of Neurosciences, KU Leuven, 3000 Leuven, Belgium
8Psychiatry, University Hospitals Leuven, 3000 Leuven, Belgium
9Surgical Oncology, University Hospitals Leuven, 3000 Leuven, Belgium
10Radiology, University Hospitals Leuven, 3000 Leuven, Belgium
*Correspondence: gwen.schroyen@kuleuven.be
†These authors contributed equally to this work.
Received 2023 Apr 12; Accepted 2023 May 10; Collection date 2023 Jun.
© 2023 by the authors.
Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).